The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,007,673 in first-year total cost, median $1,041,021.
Most frequent study sections
- Special Emphasis Panel[ZDA1 JXR-D (12)]3
Most frequent institutions
- SCRIPPS RESEARCH INSTITUTE, THE1
- TRIA BIOSCIENCE CORPORATION1
- UNIVERSITY OF KENTUCKY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Preclinical development of a TriCoil-based nicotine vaccine1UH2DA041162-01 | CLEGG, CHRISTOPHER H | TRIA BIOSCIENCE CORPORATION, WA | $1,174,182 | ZDA1 |
| 2015 | Development of Long-acting Cocaine Hydrolase as a Treatment for Cocaine Abuse1UH2DA041115-01 | ZHAN, CHANG-GUO | UNIVERSITY OF KENTUCKY, KY | $1,041,021 | ZDA1 |
| 2015 | Immunopharmacotherapy for Mitigating Opioid Addiction1UH2DA041146-01 | JANDA, KIM | SCRIPPS RESEARCH INSTITUTE, THE, CA | $792,470 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.